Description
Yangling JITAI Pharmaceutical Co., Ltd is a comprehensive provider within the pharmaceutical sector, specialising in Contract Manufacturing (CMO/CDMO), Contract Research Organisation (CRO) activities, and distribution of pharmaceutical products. Established in 2002 with a start-up capital of RMB60 million, the company has developed into a modern GMP manufacturer, focusing on the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and food production. The company also boasts a dedicated R&D lab centre, primarily undertaking DMO services for APIs and Finished Pharmaceutical Products (FPP), facilitating both pilot testing and large-scale production for new drugs.
Services include:
– APIs (Active Pharmaceutical Ingredients)
– Pharmaceuticals production
– Intermediates manufacturing
– Food production
– Research and Development (R&D) services
– Pilot test and production services for new drugs
Yangling JITAI Pharmaceutical Co., Ltd stands as a reliable partner in the pharmaceutical industry, committed to quality and innovation. For more information, please visit .
Capabilities
Contact Information
Related Listings

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel










